Sign in or Register   Sign in or Register
  |  

Rabbit Anti-GPRC5A Recombinant Antibody (D4S7D) (CBMAB-R0536-CN)

This product is a Rabbit antibody that recognizes GPRC5A. The antibody D4S7D can be used for immunoassay techniques such as: WB, IP, IHC-p, IF.
See all GPRC5A antibodies

Summary

Host Animal
Rabbit
Specificity
Human
Clone
D4S7D
Application
WB, IP, IHC-p, IF

Basic Information

Immunogen
Synthetic peptide corresponding to residues surrounding Val295 of human RAIG1 protein.
Specificity
Human
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Buffer
HEPES, pH 7.5, 100 µg/ml BSA, 50% glycerol
Preservative
0.02% sodium azide

Target

Full Name
G protein-coupled receptor class C group 5 member A
Introduction
This gene encodes a member of the type 3 G protein-coupling receptor family, characterized by the signature 7-transmembrane domain motif. The encoded protein may be involved in interaction between retinoid acid and G protein signalling pathways. Retinoic acid plays a critical role in development, cellular growth, and differentiation. This gene may play a role in embryonic development and epithelial cell differentiation. [provided by RefSeq, Jul 2008]
Entrez Gene ID
9052
UniProt ID
Q8NFJ5
Alternative Names
G Protein-Coupled Receptor Class C Group 5 Member A; G-Protein Coupled Receptor Family C Group 5 Member A; Retinoic Acid-Induced Gene 1 Protein; Phorbol Ester Induced Gene 1; Retinoic Acid Induced 3; GPCR5A; PEIG-1; RAIG1; RAI3;
Function
Orphan receptor. Could be involved in modulating differentiation and maintaining homeostasis of epithelial cells. This retinoic acid-inducible GPCR provide evidence for a possible interaction between retinoid and G-protein signaling pathways. Functions as a negative modulator of EGFR signaling (By similarity).

May act as a lung tumor suppressor (PubMed:18000218).
Biological Process
Negative regulation of epidermal growth factor-activated receptor activity Source: UniProtKB
Signal transduction Source: ProtInc
Cellular Location
Cell membrane; Cytoplasmic vesicle membrane. Localized in perinuclear vesicles, probably Golgi-associated vesicles.
Topology
Extracellular: 1-33
Helical: 34-54
Cytoplasmic: 55-68
Helical: 69-89
Extracellular: 90-97
Helical: 98-118
Cytoplasmic: 119-129
Helical: 130-150
Extracellular: 151-176
Helical: 177-197
Cytoplasmic: 198-212
Helical: 213-233
Extracellular: 234-247
Helical: 248-268
Cytoplasmic: 269-357
PTM
Phosphorylated in two conserved double-tyrosine motifs, TYR-317/TYR-320 and TYR-347/TYR-350, by EGFR; leading to inactivation of the tumor suppressive function of GPRC5A in lung cancer cells. TYR-317 and TYR-320 are the preferred residues responsible for EGFR-mediated GPRC5A phosphorylation.

Wei, R., Qi, G., Zeng, Z., Shen, N., Wang, Z., Shen, H., ... & Wang, C. (2021). IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma. Cancer Cell International, 21, 1-19.

Moyano‐Galceran, L., Pietilä, E. A., Turunen, S. P., Corvigno, S., Hjerpe, E., Bulanova, D., ... & Lehti, K. (2020). Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer. EMBO molecular medicine, 12(4), e11177.

Sawada, Y., Kikugawa, T., Iio, H., Sakakibara, I., Yoshida, S., Ikedo, A., ... & Imai, Y. (2020). GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer. International Journal of Cancer, 146(5), 1369-1382.

Wang, T., Jing, B., Xu, D., Liao, Y., Song, H., Sun, B., ... & Deng, J. (2020). PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model. Oncogene, 39(15), 3179-3194.

Richter, L., Oberländer, V., & Schmidt, G. (2020). RhoA/C inhibits proliferation by inducing the synthesis of GPRC5A. Scientific Reports, 10(1), 12532.

Greenhough, A., Bagley, C., Heesom, K. J., Gurevich, D. B., Gay, D., Bond, M., ... & Williams, A. C. (2018). Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis. EMBO molecular medicine, 10(11), e8699.

Gu, C., Zhou, N., Wang, Z., Li, G., Kou, Y., Yu, S., ... & Tian, F. (2018). circGprc5a promoted bladder oncogenesis and metastasis through Gprc5a-targeting peptide. Molecular Therapy-Nucleic Acids, 13, 633-641.

Jiang, X., Xu, X., Wu, M., Guan, Z., Su, X., Chen, S., ... & Teng, L. (2018). GPRC5A: an emerging biomarker in human cancer. BioMed Research International, 2018.

Liu, B., Yang, H., Pilarsky, C., & Weber, G. F. (2018). The effect of GPRC5a on the proliferation, migration ability, chemotherapy resistance, and phosphorylation of GSK-3β in pancreatic cancer. International journal of molecular sciences, 19(7), 1870.

Ma, X., Schwarz, A., Sevilla, S. Z., Levin, A., Hultenby, K., Wernerson, A., ... & Patrakka, J. (2018). Depletion of Gprc5a promotes development of diabetic nephropathy. Journal of the American Society of Nephrology, 29(6), 1679-1689.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Rabbit Anti-GPRC5A Recombinant Antibody (D4S7D)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare